Myfortic 180 MG tablet 120S
Ended Awarded Last action
- Contract number
- SPE2DR26FE7L8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,340
Award facts
- Contract value 100% obligated
- $15,339.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,339.68 to AmerisourceBergen Drug Corp for the supply of Myfortic 180 mg tablets (120-count units) on November 24, 2025, with an ultimate completion date of November 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 through December 2026 and serves as the company's primary vehicle for supplying pharmaceutical products and medical supplies to federal military and veteran healthcare systems worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement through the DLA Medical Supply Chain. The company's extensive portfolio under the SPE2DX contract encompasses specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains, supporting customers including the Defense Health Agency and U.S. Coast Guard. This delivery order for Myfortic, an immunosuppressant medication, exemplifies the company's role in supplying specialized pharmaceutical products to support military healthcare programs globally.
Quick answers
Who was awarded contract SPE2DR26FE7L8?
SPE2DR26FE7L8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DR26FE7L8 worth?
The government has obligated $15,340 on SPE2DR26FE7L8.
Is contract SPE2DR26FE7L8 an order under another contract?
Yes. SPE2DR26FE7L8 is a delivery order under SPE2DR25D2005, an indefinite delivery contract.
Was contract SPE2DR26FE7L8 competed?
The extent of competition for SPE2DR26FE7L8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award